Fondaparinux (Arixtra)


Indications

Acute Coronary Syndrome (ACS) (see Coronary Artery Disease, [[Coronary Artery Disease]])

Systemic Embolism Prophylaxis in Atrial Fibrillation (see Atrial Fibrillation, [[Atrial Fibrillation]])

Venous Thromboembolism-Deep Venous Thrombosis (DVT)/Acute Pulmonary Embolism (PE) (see Deep Venous Thrombosis, [[Deep Venous Thrombosis]] and Acute Pulmonary Embolism, [[Acute Pulmonary Embolism]])

Deep Venous Thrombosis (DVT) Prophylaxis After Knee/Hip Replacement (see Deep Venous Thrombosis, [[Deep Venous Thrombosis]])

Heparin-Induced Thrombocytopenia (HIT) (see Heparin-Induced Thrombocytopenia, [[Heparin-Induced Thrombocytopenia]])


Pharmacology

Metabolism


Administration

Dose Adjustment

Effect on Anticoagulation Tests


Adverse Effects

Hematologic Adverse Effects

Heparin-Induced Thrombocytopenia (HIT) (see Heparin-Induced Thrombocytopenia, [[Heparin-Induced Thrombocytopenia]])

Hemorrhagic Adverse Effects


References